ISSN 1300-4948 | E-ISSN 2148-5607
RELATED ARTICLES
Editorial
The relationship between cagA positivity and serum gastrin and TNF- alpha levels in patients with chronic active gastritis and duodenal ulcer associated with Helicobacter pylori
(Turk J Gastroenterol 1999; 10: 385-390)
Gastro-esophageal reflux following Helicobacter pylori eradication
(Turk J Gastroenterol 1999; 10: 411-418)
Intragastric distribution of Helicobacter pylori after eradication therapy
(Turk J Gastroenterol 2000; 11: 20-24)
A comparison of lansoprazole and omeprazole based triple combinations for the treatment of Helicobacter pylori associated gastritis and peptic ulcer
(Turk J Gastroenterol 2000; 11: 25-29)
Helicobacter pylori and antibiotic resistance
(Turk J Gastroenterol 2000; 11: 141-145)
The effect of CagA status on response to Helicobacter pylori eradication therapy
(Turk J Gastroenterol 2000; 11: 146-149)
The clinical role of stool test (HpSA) in noninvasive diagnosis of Helicobacter pylori infection
(Turk J Gastroenterol 2000; 11: 97-102)
Systemic cellular immune response in Helicobacter pylori associated duodenal ulcer and chronic antral gastritis
(Turk J Gastroenterol 2000; 11: 208-211)
Re-bleeding in patients following Helicobacter pylori eradication therapy for bleeding peptic ulcer:Results of 18 month-follow up
(Turk J Gastroenterol 2000; 11: 212-215)
The effects of alcohol on gastric mucosa and gastric emptying time
(Turk J Gastroenterol 2000; 11: 216-221)
Colonization of Helicobacter pylori–like organisms on the ectopic gastric mucosa of Meckel’s diverticulum:A case report*
(Turk J Gastroenterol 2000; 11: 264-266)
Is lower socio-economic status a risk factor for Helicobacter pylori infection in pregnant women with hyperemesis gravidarum?
(Turk J Gastroenterol 2004; 15: 86-89)
Comparison of ranitidine bismuth citrate, tetracycline and metronidazole with ranitidine bismuth citrate and azithromycin for the eradication of Helicobacter pylori in patients resistant to PPI based triple therapy
(Turk J Gastroenterol 2004; 15: 90-93)
The relation of Helicobacter pylori with intestinal metaplasia, gastric atrophy and BCL-2
(Turk J Gastroenterol 2004; 15: 149-155)
*Changes in the seroepidemiological pattern of Helicobacter pylori infection over the last 10 years in Turkey
(Turk J Gastroenterol 2004; 15: 156-158)
The effect of Helicobacter pylori eradication in patients with functional dyspepsia: Assessment of different diagnostic tests
(Turk J Gastroenterol 2004; 15: 159-163)
Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori
(Turk J Gastroenterol 2004; 15: 219-224)
Predictive value of tissue cagA status in Helicobacter pylori infection
(Turk J Gastroenterol 2001; 12: 27-31)
*The Sydney System in the assessment of gastritis: Inter-observer agreement
(Turk J Gastroenterol 2001; 12: 36-39)
Can resistant Helicobacter pylori infection be estimated histologically: Effects of gastric histology on eradication rates of Helicobacter pylori infection
(Turk J Gastroenterol 2001; 12: 126-129)
Effects of Helicobacter pylori and liver cirrhosis on gastric mucosal hexosamine concentrations
(Turk J Gastroenterol 2001; 12: 206-210)
Does Helicobacter pylori infection have a role in coronary artery disease?
(Turk J Gastroenterol 2001; 12: 287-293)
The effect of Helicobacter pylori eradication on symptoms and gastric emptying in patients with nonulcer dyspepsia
(Turk J Gastroenterol 2002; 13: 146-153)
Relationship between gastritis severity, Helicobacter pylori intensity and mast cell density in the antrum and corpus
(Turk J Gastroenterol 2002; 13: 154-158)
Does eradication of Helicobacter pylori infection reduce hypergastrinema during long term therapy with proton pump inhibitors?
(Turk J Gastroenterol 2002; 13: 159-163)
Serum levels of acute phase proteins in patients with nonalcoholic steatohepatitis
(Turk J Gastroenterol 2003; 14: 12-17)
The association of short segment Barrett's esophagus with intestinal metaplasia in stomach
(Turk J Gastroenterol 2003; 14: 33-38)
The researched of Helicobacter pylori incidence on Turkish population who have been living in Germany
(Turk J Gastroenterol 1996; 7: 61-64)
An effective and economic approach for the eradication of Helicobacter Pylori:omeprazole and two antibiotic combination
(Turk J Gastroenterol 1996; 7: 228-232)
Prevelance of Helicobacter pylori in patients with of without dyspepsia and comparsion of different methods in the diagnosis of helicobacter pylori
(Turk J Gastroenterol 1996; 7: 223-236)
Prevelance of helicobacter pylori infection among Turkish living in or near Stutgart Germany, and the effect of triple therapy (pantoprazole-clarithomycin-metronidzole) on Helicobacter pylori infection
(Turk J Gastroenterol 1996; 7: 237-239)
Gastric emptying time in patients with primary hypothyroidism
(Turk J Gastroenterol 1996; 7: 240-243)
The effect of eradaicating helicobacter pylori infection on intragastric pH and serum gastrin concentrations
(Turk J Gastroenterol 1996; 7: 331-334)
Expression of class I and II MHC receptors in Helicobacter pylori-positive patients with active gastritis and duodenal ulcer*
(Turk J Gastroenterol 2003; 14: 168-172)
The importance of iron and copper accumulation in the pathogenesis of non-alcoholic steatohepatitis
(Turk J Gastroenterol 2003; 14: 228-233)
The effect of duodenogastric reflux on Helicobacter pylori presence and gastric histopathologic changes
(Turk J Gastroenterol 2003; 14: 239-242)
Seroprevalence of anti-Helicobacter pylori and anti-CagA antibodies among healthy children according to age, sex, ABO blood groups and Rh status in south-east of Iran
(Turk J Gastroenterol 2007; 18: 165-171)
Seroprevalence of Helicobacter pylori in children with constitutional height retardation
(Turk J Gastroenterol 2006; 17: 7-12)
PCNA expression in chronic gastritis due to Helicobacter pylori*
(Turk J Gastroenterol 2006; 17: 84-89)
Bismuth-based therapies for the first step eradication of Helicobacter pylori
(Turk J Gastroenterol 2006; 17: 90-93)
Effect of single dose alcohol administration on malondialdehyde, glutathione,total protein and hydroxproline levels of rat liver
(Turk J Gastroenterol 1999; 10: 1-3)
Efficacy of combination therapy with omeprazole, amoxicillin and clarithromycin for treatment of patients with Helicobacter pylori associated gastritis and duodenal ulcer disease
(Turk J Gastroenterol 1999; 10: 27-31)
Evaluation of chronic gastritis in patients with Helicobacter pylori associated gastritis, gastroduodenitis and duodenal ulcer disease
(Turk J Gastroenterol 1999; 10: 32-35)
Helicobacter pylori infection in gastric carcinoma in the Van region of Turkey
(Turk J Gastroenterol 1999; 10: 36-39)
Factors related to non-alcoholic fatty liver disease in obese children
(Turk J Gastroenterol 2008; 19: 85-91)
The association of Helicobacter Pylori with gastric epithelial cell proliferation
(Turk J Gastroenterol 1998; 9: 349-353)
The comparsion of lansoprazole and omeprazole in the one-week triple therapy for the eradication of Helicobacter Pylori
(Turk J Gastroenterol 1998; 9: 354-357)
Low prevalence of erosive esophagitis and Barrett esophagus in a tertiary referral center in Turkey
(Turk J Gastroenterol 2008; 19: 146-151)
The effect of decrease in serum nitric oxide concentration on portal hemodynamics after Helicobacter pylori treatment: An open-label pilot study
(Turk J Gastroenterol 2008; 19: 158-162)
Detection of point mutations on 23S rRNA of Helicobacter pylori and resistance to clarithromycin with PCR-RFLP in gastric biopsy specimens in Mersin, Turkey
(Turk J Gastroenterol 2008; 19: 163-167)
Obesity and related parameters of non-alcoholic steatohepatitis
(Turk J Gastroenterol 2002; 13: 71-77)
Detection of Helicobacter pylori using nested polymerase chain reaction and rapid urease test in gastric biopsy samples
(Turk J Gastroenterol 2002; 13: 94-97)
The relationship between Helicobacter pylori intensity and histopathological findings in cases with chronic gastritis and duodenal ulcer
(Turk J Gastroenterol 2002; 13: 98-102)
The prevalence of manifest and latent celiac disease in type 1 diabetes mellitus
(Turk J Gastroenterol 2002; 13: 103-107)
Influence of CYP2C19 functional polymorphism on Helicobacter pylori eradication
(Turk J Gastroenterol 2010; 21: 23-28)
DOI: 10.4318/tjg.2010.0043
Anadoluda anne ve bebeklerinde Helikobakter pilori enfeksiyonu
(Turk J Gastroenterol 2010; 21: 113-118)
DOI: 10.4318/tjg.2010.0067
Efficacy of probiotics in Helicobacter pylori eradication therapy
(Turk J Gastroenterol 2010; 21: 212-217)
DOI: 10.4318/tjg.2010.0090
Effectiveness of different treatment regimens in helicobacter pylori eradication: Ten-year experience of a single institution
(Turk J Gastroenterol 2010; 21: 218-223)
DOI: 10.4318/tjg.2010.0091
Gallstones associated with nonalcoholic steatohepatitis (NASH) and metabolic syndrome
(Turk J Gastroenterol 2010; 21: 411-415)
DOI: 10.4318/tjg.2010.0128
Risk of Helicobacter pylori infection in newborn babies of Helicobacter pylori-positive pregrant woman
(Turk J Gastroenterol 1998; 9: 36-39)
One-week triple her therapies for Helicobacter pylori eradication
(Turk J Gastroenterol 1998; 9: 40-45)
Duodenal ulcer healing with one week therapy
(Turk J Gastroenterol 1998; 9: 46-49)
Helicobacter pylori and cobalamin deficiency
(Turk J Gastroenterol 1998; 9: 126-132)
The role of gastric juice ammonia and gastric huice urea nitrogen/ammonia in the diagnosis of Helicobacter pylori infection
(Turk J Gastroenterol 1998; 9: 133-137)
Helicobacter pylori seroprevalence in children, aged 6 months to 5 years old, in Turkey
(Turk J Gastroenterol 1998; 9: 138-145)
Recurrence rates after Helicobacter pylori eradication
(Turk J Gastroenterol 1998; 9: 154-158)
The type and localization of gastritis in patients with dudenal ulcer and relationship to helicobacter pylori
(Turk J Gastroenterol 1998; 9: 167-171)
Apoptosis in selected liver diseases
(Turk J Gastroenterol 2009; 20: 171-179)
DOI: 10.4318/tjg.2009.0003
Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
(Turk J Gastroenterol 2005; 16: 29-33)
Assessment of lipid peroxidation and antioxidant capacity in non-alcoholic fatty liver disease
(Turk J Gastroenterol 2005; 16: 65-70)
A new marker for lipid peroxidation: Serum paraoxonase activity in non-alcoholic steatohepatitis
(Turk J Gastroenterol 2005; 16: 119-123)
The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases
(Turk J Gastroenterol 2005; 16: 203-206)
The effect of different dosage and duration of lansoprazole-clarithromycin- amoxycillin combination on Helicobacter pylori eradication
(Turk J Gastroenterol 1999; 10: 115-117)
Changes in the degree of gastritis during the treatment of duodenal ulcer
(Turk J Gastroenterol 1999; 10: 118-121)
The diagnostic role of ultrasonography in liver steatosis
(Turk J Gastroenterol 1999; 10: 96-100)
Prevelance of Helicobacter pylori in dyspeptic patients
(Turk J Gastroenterol 1997; 8: 66-70)
Effect of omeprazole, claritomycine and amoxiciline therapy on duodenal ulcer and Helicobacter pylori eradication
(Turk J Gastroenterol 1997; 8: 71-73)
Determination of primary resistance of Helicobacter pylori isolates to clarithromycin and amoxicilin by disc difussion method and the comparison with resistance in recurrent cases
(Turk J Gastroenterol 1997; 8: 309-312)
The prevalence of lymphoid follicles and intestinal metaplasia in Helicobacter pylori associated clinically significant gastroduodenal diseases
(Turk J Gastroenterol 1999; 10: 197-201)
Ranitidine bismuth citrate based dual and triple therapies in Helicobacter pylori eradication
(Turk J Gastroenterol 1999; 10: 202-206)
Nitric oxide oxidation products in the serum of patients with gastric and esophageal cancer and Helicobacter pylori
(Turk J Gastroenterol 1999; 10: 193-196)
Blind gastric biopsy in the diagnosis of Helicobacter Pylori infection
(Turk J Gastroenterol 1997; 8: 440-442)
Surgical management of perforated dudenal ulcers
(Turk J Gastroenterol 1997; 8: 447-453)
The importance of Candida in a cade with refactory duodenal ulcer
(Turk J Gastroenterol 1997; 8: 251-253)
Review
Apoptosis and fibrosis in non-alcoholic fatty liver disease
(Turk J Gastroenterol 2005; 16: 1-6)
Nonalcoholic fatty liver disease: Diagnosis, pathogenesis, and management
(Turk J Gastroenterol 2014; 25: 127-132)
DOI: 10.5152/tjg.2014.7675
Role of gut microbiota: Obesity and NAFLD
(Turk J Gastroenterol 2014; 25: 133-140)
DOI: 10.5152/tjg.2014.7886
A proposed role for diffusible signal factors in the biofilm formation and morphological transformation of Helicobacter pylori
(Turk J Gastroenterol 2018; 29: 7-13)
DOI: 10.5152/tjg.2017.17349
Gastroesophageal reflux disease and the relationship with Helicobacter pylori
(Turk J Gastroenterol 2017; 28: 61-67)
DOI: 10.5152/tjg.2017.16
Case Report
Icterohaemorrhagic leptospirosis in patients with history of alcohol abuse – report of two cases
(Turk J Gastroenterol 2013; 24: 549-555)
DOI: 10.4318/tjg.2013.0588
A case of endoscopic ultrasound diagnosis of gastric amyloidosis
(Turk J Gastroenterol 2012; 23: 769-772)
DOI: 10.4318/tjg.2012.0443
Original Article
Association of Helicobacter pylori infection with microalbuminuria in type 2 diabetic patients
(Turk J Gastroenterol 2011; 22: 569-574)
DOI: 10.4318/tjg.2011.0252
Assessment of Helicobacter pylori eradication rate of triple combination therapy containing levofloxacin
(Turk J Gastroenterol 2011; 22: 582-586)
DOI: 10.4318/tjg.2011.0255
Is there a relationship between Helicobacter pylori and gastric autoimmunity?
(Turk J Gastroenterol 2011; 22: 134-138)
DOI: 10.4318/tjg.2011.0181
The relationship between insulin resistance, metabolic syndrome and nonalcoholic fatty liver disease in non-obese non-diabetic Turkish individuals: A pilot study
(Turk J Gastroenterol 2014; 25: 63-68)
DOI: 10.5152/tjg.2014.6233
The role of interleukin-1 gene polymorphisms and Helicobacter pylori in gastroesophageal reflux disease
(Turk J Gastroenterol 2014; 25: 81-85)
DOI: 10.5152/tjg.2014.6512
Fatty liver disease might increase the risk of abdominal operation in patients with fatty liver and the prevalence of cancer in first-degree relatives
(Turk J Gastroenterol 2014; 25: 138-141)
DOI: 10.5152/tjg.2014.7674
A comparison of the effects of infliximab, adalimumab, and pentoxifylline on rats with non-alcoholic steatohepatitis
(Turk J Gastroenterol 2014; 25: 167-175)
DOI: 10.5152/tjg.2014.5121
Characterization of 23S rRNA gene mutation in primary and secondary clarithromycin-resistant Helicobacter pylori strains from East China
(Turk J Gastroenterol 2013; 24: 5-9)
DOI: 10.4318/tjg.2013.0525
Azithromycin based triple therapy versus standard clarithromycin based triple therapy in eradication of Helicobacter pylori infection in Iran: a randomized controlled clinical trial
(Turk J Gastroenterol 2013; 24: 10-14)
DOI: 10.4318/tjg.2013.0540
Ongoing symptoms after eradication of Helicobacter pylori: Psychiatric disorders may accompany!
(Turk J Gastroenterol 2013; 24: 15-21)
DOI: 10.4318/tjg.2013.0582
A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazolebased triple therapy for the eradication of Helicobacter pylori in dyspeptic patients
(Turk J Gastroenterol 2013; 24: 316-321)
DOI: 10.4318/tjg.2013.0509
Ornidazole-based sequential therapy is not effective in Helicobacter pylori eradication in children
(Turk J Gastroenterol 2013; 24: 382-386)
DOI: 10.4318/tjg.2013.0575
Evaluation of serum ghrelin levels in patients with hyperplastic gastric polyps
(Turk J Gastroenterol 2012; 23: 444-447)
DOI: 10.4318/tjg.2012.0424
Assessment of COX-2 expression presence and severity by immunohistochemical method in patients with chronic active gastritis and intestinal metaplasia
(Turk J Gastroenterol 2012; 23: 478-484)
DOI: 10.4318/tjg.2012.0432
Does Helicobacter pylori treatment improve the symptoms of globus hystericus?
(Turk J Gastroenterol 2012; 23: 681-685)
DOI: 10.4318/tjg.2012.0507
Relationship between serum aminotransferase levels and metabolic disorders in northern China
(Turk J Gastroenterol 2012; 23: 699-707)
DOI: 10.4318/tjg.2012.0589
Measurement of the coronary flow velocity reserve in patients with non-alcoholic fatty liver disease
(Turk J Gastroenterol 2012; 23: 720-726)
DOI: 10.4318/tjg.2012.0489
The diagnostic accuracy of urine IgG antibody tests for the detection of Helicobacter pylori infection in Turkish dyspeptic patients
(Turk J Gastroenterol 2012; 23: 753-758)
DOI: 10.4318/tjg.2012.0497
Increased plasma CgA levels associated with nonalcoholic fatty liver disease
(Turk J Gastroenterol 2015; 26: 404-407)
DOI: 10.5152/tjg.2015.0075
The development of a clinical score for the prediction of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease using routine parameters
(Turk J Gastroenterol 2015; 26: 408-416)
DOI: 10.5152/tjg.2015.6336
Gallstones in liver transplant recipients: A single-center study in China
(Turk J Gastroenterol 2015; 26: 429-434)
DOI: 10.5152/tjg.2014.6344
A retrospective study demonstrating properties of nonvariceal upper gastrointestinal bleeding in Turkey
(Turk J Gastroenterol 2011; 22: 249-254)
DOI: 10.4318/tjg.2011.0209
The prevalence of celiac disease among patients with non-alcoholic fatty liver disease in Iran
(Turk J Gastroenterol 2011; 22: 300-304)
DOI: 10.4318/tjg.2011.0216
A new risk factor for the development of non-alcoholic fatty liver disease: HLA complex genes
(Turk J Gastroenterol 2011; 22: 395-399)
DOI: 10.4318/tjg.2011.0237
Helicobacter pylori and histopathological findings in patients with dyspepsia
(Turk J Gastroenterol 2011; 22: 122-127)
DOI: 10.4318/tjg.2011.0179
Sclerotherapy of simple hepatic cysts by repeated aspiration and alcohol instillation
(Turk J Gastroenterol 2012; 23: 359-365)
DOI: 10.4318/tjg.2012.0349
Helicobacter pylori infection and administration of non-steroidal anti-inflammatory drugs down-regulate the expression of gastrokine-1 in gastric mucosa
(Turk J Gastroenterol 2012; 23: 212-219)
DOI: 10.4318/tjg.2012.0345
Noninvasive assessment of portal hypertension in patients with alcoholic cirrhosis
(Turk J Gastroenterol 2012; 23: 239-246)
DOI: 10.4318/tjg.2012.0463
Effects of probiotics on methionine cholinedeficient diet-induced steatohepatitis in rats
(Turk J Gastroenterol 2012; 23: 110-121)
DOI: 10.4318/tjg.2012.0330
Comparison of bismuth-containing quadruple and concomitant therapies as a first-line treatment option for Helicobacter pylori
(Turk J Gastroenterol 2012; 23: 8-13)
DOI: 10.4318/tjg.2012.0392
Furazolidone, amoxicillin and omeprazole with or without bismuth for eradication of Helicobacter pylori in peptic ulcer disease
(Turk J Gastroenterol 2011; 22: 1-5)
DOI: 10.4318/tjg.2011.0148
Influence of vitamin C and E supplementation on the eradication rates of triple and quadruple eradication regimens for Helicobacter pylori infection
(Turk J Gastroenterol 2015; 26: 456-460)
DOI: 10.5152/tjg.2015.0233
Effect of pantoprazole and Helicobacter pylori therapy on uninvestigated dyspeptic patients
(Turk J Gastroenterol 2015; 26: 6-14)
DOI: 10.5152/tjg.2015.0010
Is there any association between colonic polyps and gastric intestinal metaplasia?
(Turk J Gastroenterol 2016; 27: 221-226)
DOI: 10.5152/tjg.2016.15212
Relationship between Helicobacter pylori infection and metabolic syndrome
(Turk J Gastroenterol 2015; 26: 468-473)
DOI: 10.5152/tjg.2015.0197
Decreasing prevalence of Helicobacter pylori according to birth cohorts in urban China
(Turk J Gastroenterol 2017; 28: 94-97)
DOI: 10.5152/tjg.2017.16557
Promotional effect of nonalcoholic fatty liver disease on Gallstone disease: A systematic review and meta-analysis
(Turk J Gastroenterol 2017; 28: 31-39)
DOI: 10.5152/tjg.2016.0357
The importance of upper gastrointestinal endoscopy in morbidly obese patients
(Turk J Gastroenterol 2015; 26: 228-231)
DOI: 10.5152/tjg.2015.0083
Ovaries are more vulnerable than hepatocytes for insulin resistance and hyperinsulinemia
(Turk J Gastroenterol 2016; 27: 62-67)
DOI: 10.5152/tjg.2015.150473
Role of oxidative stress and insulin resistance in disease severity of non-alcoholic fatty liver disease
(Turk J Gastroenterol 2016; 27: 361-366)
DOI: 10.5152/tjg.2016.16106
Effect of SIRS and sepsis on mortality in alcoholic hepatitis: A systematic review and meta-analysis
(Turk J Gastroenterol 2016; 27: 458-463)
DOI: 10.5152/tjg.2016.16188
Gastrointestinal Tract - Original Article
Role of toll-like receptor 10 gene polymorphism and gastric mucosal pattern in patients with chronic gastritis
(Turk J Gastroenterol 2017; 28: 243-247)
DOI: 10.5152/tjg.2017.16673
Combined treatment for gastric cancer: Immunological approach
(Turk J Gastroenterol 2018; 29: 151-156)
DOI: 10.5152/tjg.2018.17398
Does Helicobacter pylori infection influence the major postoperative complication rate after sleeve gastrectomy? A retrospective cohort study in an endemic region
(Turk J Gastroenterol 2018; 29: 379-383)
DOI: 10.5152/tjg.2018.17373
Association of a single nucleotide polymorphism in the TLR2 gene (rs3804099), but not in the TLR4 gene (rs4986790), with Helicobacter pylori infection and peptic ulcer
(Turk J Gastroenterol 2018; 29: 283-291)
DOI: 10.5152/tjg.2018.17484
Potential role of chromatin remodeling factor genes in atrophic gastritis/gastric cancer risk
(Turk J Gastroenterol ; : -)
DOI: 10.5152/tjg.2018.17350
Potential role of chromatin remodeling factor genes in atrophic gastritis/gastric cancer risk
(Turk J Gastroenterol 2018; 29: 427-435)
DOI: 10.5152/tjg.2018.17350
Comparison of 10 and 14 days of triple therapy versus 10 days of sequential therapy for Helicobacter pylori eradication: A prospective randomized study
(Turk J Gastroenterol ; : -)
DOI: 10.5152/tjg.2018.17707
Role of screening colonoscopy for colorectal tumors in Helicobacter pylori-related chronic gastritis with MDM2 SNP309 G/G homozygous: A prospective cross-sectional study in Thailand
(Turk J Gastroenterol ; : -)
DOI: 10.5152/tjg.2018.17608
Does Helicobacter pylori infection influence the major postoperative complication rate after sleeve gastrectomy? A retrospective cohort study in an endemic region
(Turk J Gastroenterol ; : -)
DOI: 10.5152/tjg.2018.17373
Liver - Original Article
Effects of Delta-tocotrienol Supplementation on Liver Enzymes, Inflammation, Oxidative stress and Hepatic Steatosis in Patients with Nonalcoholic Fatty Liver Disease
(Turk J Gastroenterol 2018; 29: 170-176)
DOI: 10.5152/tjg.2018.17297
Determination of certain bacterial groups in gut microbiota and endotoxin levels in patients with nonalcoholic steatohepatitis
(Turk J Gastroenterol 2017; 28: 361-369)
DOI: 10.5152/tjg.2017.17033
Pediatric Gastroenterology - Original Article
Effects of long-term synbiotic supplementation in addition to lifestyle changes in children with obesity-related non-alcoholic fatty liver disease
(Turk J Gastroenterol 2017; 28: 377-383)
DOI: 10.5152/tjg.2017.17084
Key Words
Authors
All
Reviewer's Corner
Author’s Corner
Survey
AVES | Copyright © 2018 Turkish Society of Gastroenterology | Latest Update: 29.06.2018